Literature DB >> 17678648

rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease.

Fredric P Manfredsson1, Corinna Burger, Layla F Sullivan, Nicholas Muzyczka, Alfred S Lewin, Ronald J Mandel.   

Abstract

We hypothesized that over-expressing the E3 ligase, parkin, whose functional loss leads to Parkinson's disease, in the nigrostriatal tract might be protective in the unilateral 6-hydroxydopamine (6-OHDA) rat lesion model. Recombinant adeno-associated virus (rAAV) encoding human parkin or green fluorescent protein (GFP) was injected into the rat substantia nigra 6 weeks prior to a four-site striatal 6-OHDA lesion. Vector-mediated parkin over-expression significantly ameliorated motor deficits as measured by amphetamine-induced rotational behavior and spontaneous behavior in the cylinder test but forelimb akinesia as assessed by the stepping test was unaffected. rAAV-mediated human parkin was expressed in the nigrostriatal tract, the substantia pars reticulata, and the subthalamic nucleus. However, in lesioned animals, there was no difference between nigral parkin and GFP-transduction on lesion-induced striatal tyrosine hydroxylase (TH) innervation or nigral TH positive surviving neurons. A second lesion experiment was performed to determine if striatal dopamine (DA) neurotransmission was enhanced as measured biochemically. In this second group of parkin and GFP treated rats, behavioral improvement was again observed. In addition, striatal TH and DA levels were slightly increased in the parkin-transduced group. In a third experiment, we evaluated parkin and GFP transduced rats 6 weeks after vector injection without DA depletion. When challenged with amphetamine, parkin treated rats tended to display asymmetries biased away from the treated hemisphere. Nigral parkin over-expression induced increases in both striatal TH and DA levels. Therefore, while parkin over-expression exerted no protective effect on the nigrostriatal DA system, parkin appeared to enhance the efficiency of nigrostriatal DA transmission in intact nigral DA neurons likely due to the observed increases in TH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17678648     DOI: 10.1016/j.expneurol.2007.06.019

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  34 in total

Review 1.  Parkinson's disease: gene therapies.

Authors:  Philippe G Coune; Bernard L Schneider; Patrick Aebischer
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

2.  Parkin Overexpression Ameliorates PrP106-126-Induced Neurotoxicity via Enhanced Autophagy in N2a Cells.

Authors:  Sher Hayat Khan; Deming Zhao; Syed Zahid Ali Shah; Mohammad Farooque Hassan; Ting Zhu; Zhiqi Song; Xiangmei Zhou; Lifeng Yang
Journal:  Cell Mol Neurobiol       Date:  2016-07-18       Impact factor: 5.046

3.  Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model.

Authors:  Sara E Gombash; Jack W Lipton; Timothy J Collier; Lalitha Madhavan; Kathy Steece-Collier; Allyson Cole-Strauss; Brian T Terpstra; Anne L Spieles-Engemann; Brian F Daley; Susan L Wohlgenant; Valerie B Thompson; Fredric P Manfredsson; Ronald J Mandel; Caryl E Sortwell
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

Review 4.  Gene therapy targeting mitochondrial pathway in Parkinson's disease.

Authors:  Chi-Jing Choong; Hideki Mochizuki
Journal:  J Neural Transm (Vienna)       Date:  2016-09-16       Impact factor: 3.575

Review 5.  Versatile somatic gene transfer for modeling neurodegenerative diseases.

Authors:  Ronald L Klein; David B Wang; Michael A King
Journal:  Neurotox Res       Date:  2009-08-11       Impact factor: 3.911

6.  Effects of aging and levodopa on the laryngeal adductor reflex in rats.

Authors:  Xin Feng; Zengrui Xu; Susan G Butler; Iris Leng; Tan Zhang; Stephen B Kritchevsky
Journal:  Exp Gerontol       Date:  2012-07-21       Impact factor: 4.032

7.  Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat.

Authors:  Irene Avila; Louise C Parr-Brownlie; Elena Brazhnik; Edward Castañeda; Debra A Bergstrom; Judith R Walters
Journal:  Exp Neurol       Date:  2009-12-04       Impact factor: 5.330

8.  Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesity.

Authors:  Fredric P Manfredsson; Nihal Tumer; Benedek Erdos; Tessa Landa; Christopher S Broxson; Layla F Sullivan; Aaron C Rising; Kevin D Foust; Yi Zhang; Nicholas Muzyczka; Oleg S Gorbatyuk; Philip J Scarpace; Ronald J Mandel
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

9.  Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.

Authors:  Bin Liu; Roberta Traini; Bryan Killinger; Bernard Schneider; Anna Moszczynska
Journal:  Exp Neurol       Date:  2013-01-09       Impact factor: 5.330

10.  Tight Long-term dynamic doxycycline responsive nigrostriatal GDNF using a single rAAV vector.

Authors:  Fredric P Manfredsson; Corinna Burger; Aaron C Rising; Kheir Zuobi-Hasona; Layla F Sullivan; Alfred S Lewin; Julia Huang; Emily Piercefield; Nicholas Muzyczka; Ronald J Mandel
Journal:  Mol Ther       Date:  2009-08-25       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.